Ruichu Medicine
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- Undisclosed
Investors
- 4
About Ruichu Medicine
Established in 2021 and based in Nanjing, China, Ruichu Medicine is a pharmaceutical company that focuses on developing drugs for degenerative diseases. The company's founding team has more than 10 years of experience in the field of ageing research. The company is dedicated to the development of therapeutic drugs target for degenerative diseases, including neurodegenerative, fibrotic, and inflammatory diseases. The company generates revenue by providing therapeutic drugs target for degenerative diseases.
Who invested in Ruichu Medicine
4 investors across 2 rounds
See all investors in Ruichu Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ruichu Medicine
Who invested in Ruichu Medicine?
Ruichu Medicine has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruichu Medicine raised?
Ruichu Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ruichu Medicine last raise money?
Ruichu Medicine's most recent round on record is a Series A, in Jul 2025.
What does Ruichu Medicine do?
Established in 2021 and based in Nanjing, China, Ruichu Medicine is a pharmaceutical company that focuses on developing drugs for degenerative diseases.
Where is Ruichu Medicine headquartered?
Ruichu Medicine is headquartered in Nanjing, China.
Which VCs invest in companies like Ruichu Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Ruichu Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Ruichu Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.